Back to Search
RANJANI RAMANATHAN, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1639212335IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
2007022069(MO)
Education
OTHER
Class of 2002
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Phase I study of weekly (day 1 and 8) docetaxel in combination with capecitabine in patients with advanced solid malignancies.
PMID 15723261·Cancer Chemother Pharmacol·2005
3-trial
Phase I pharmacokinetic-pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin (17AAG, NSC 330507), a novel inhibitor of heat shock protein 90, in patients with refractory advanced cancers.
PMID 15867239·Clin Cancer Res·2005
3-trial
Application of semi-automated metabolite identification software in the drug discovery process for rapid identification of metabolites and the cytochrome P450 enzymes responsible for their formation.
PMID 12039637·J Pharm Biomed Anal·2002
8-other
Does 3-Dimensional (3-D) visualization improve the quality of assistance during robotic radical prostatectomy?
PMID 18807048·World J Urol·2009
8-other
Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.
PMID 19461594·J Perinatol·2009
4-observational
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines.
PMID 19270293·Am J Trop Med Hyg·2009
8-other
Choosing a right surfactant for respiratory distress syndrome treatment.
PMID 18832858·Neonatology·2009
6-review
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
PMID 19487295·Cancer Res·2009
4-observational
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers.
PMID 19399502·Cancer Chemother Pharmacol·2009
3-trial
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies.
PMID 19190127·Clin Cancer Res·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 201 BJC SAINT PETERS DR STE 100
SAINT PETERS, MO 63376 - Phone
- (636) 916-7235
Quick Facts
- NPI
- 1639212335
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 24
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile